VIDA Diagnostics is the leader in precision pulmonary imaging, providing evidence-based quantitative information for early detection, evaluation, and treatment of pulmonary diseases including COPD (emphysema, chronic bronchitis), lung cancer, and asthma. VIDA’s software and services are routinely used in clinical practice, along with academic, device, and pharmaceutical clinical trials.
About The Author
Mark Minevich and Angelica Sirotin
Mark Minevich is a President of Going Global Ventures Inc., Executive Chairman Digital Pioneers Network, Chair AI Policy - IRCAI under UNESCO. Mark is Digital Cognitive Strategist, Artificial Intelligence expert, Venture Capitalist, Innovation CTO, author & columnist with more than 25 years of experience advising both International Organizations, investors and private companies, business-venture, strategy, and global technology markets. Mark is also a Sr. Advisor to Boston Consulting Group, IPSoft/Amelia, Hitachi Group, Member World Economic Forum, FutureCouncil Member, B20 with the G20 Senior Fellow, US Council on Competitiveness.
Related Posts
Recent Articles
-
The 7 Most Promising Government Led AI SolutionsNov 23, 2020 | News